comprehensive -WSS

comprehensive

author：knowledge 2025-09-28 21:05:30 - browse：1

The Food and Drug Administration on Tuesday approved brexanolone, the first drug specifically targeted to treat postpartum depression — the most common complication of childbirth. Yet it’s a condition that often goes untreated because new mothers fear being stigmatized if they report symptoms.

Brexanolone is the first drug developed by and approved from Sage Therapeutics. The Cambridge, Mass.-based biotech company will market the new medicine under the brand name Zulresso.

“This approval is important for postpartum depression patients and it’s important for our company. It’s rare in your career when you can introduce a new medicine that is different from what’s out there,” said Sage CEO Jeff Jonas.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Popular nasal decongestant doesn't actually relieve congestion

WSS

New Covid vaccine is recommended for everyone 6 months or older

The perfect storm of weather conditions that led to the devastating wildfires in Maui

Private equity could exacerbate cardiology's overuse problem, experts fear

'Disease catastrophe' looms in Sudan as health conditions deteriorate, medics warn

Novo acquires Inversago for up to $1 billion

Target recalls 2.2 million additional candles due to laceration, burn hazards

explore

comprehensive

knowledge

Affirmative action in medical school literally saved lives

Pig kidney works a record two months in donated body

What does generative AI mean for health care? We asked experts

Food makers tried to stack nutrition panel with preferred experts

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Food makers to regulators: Ultra

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Telehealth for opioid use disorder is lifesaving

Virginia high school admissions case could be legal follow

House GOP releases memo on Hunter Biden foreign business dealings, reviving old claims

hotspot

How housing is health care on Long Island

Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era

CDC overhauls leadership of center that led response to Covid

PEPFAR is under serious threat — and so is global health

TB outbreak tied to bone grafts underscores testing shortcomings

TB outbreak tied to bone grafts underscores testing shortcomings

explore

knowledge

knowledge

knowledge